XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Summary of earnings per share
The following schedule presents earnings per share data for the three-month periods ended June 30, 2023 and 2022 (in thousands, except per share data):
 
    
Three months ended
June 30,
 
    
2023
    
2022
 
Net income applicable to common stock
   $ 6,788      $ 6,327  
Weighted average number of common shares outstanding
     6,270        6,305  
  
 
 
    
 
 
 
Basic earnings per share
   $ 1.08      $ 1.00  
  
 
 
    
 
 
 
Net income applicable to common stock
   $ 6,788      $ 6,327  
Weighted average number of common shares outstanding
     6,270        6,305  
Dilutive effect on common shares outstanding
     95        132  
  
 
 
    
 
 
 
Weighted average number of diluted common shares outstanding
     6,365        6,437  
  
 
 
    
 
 
 
Diluted earnings per share
   $ 1.07      $ 0.98  
  
 
 
    
 
 
 
The following schedule presents earnings per share data for the
six-month
periods ended June 30, 2023 and 2022 (in thousands, except per share data):
 
    
Six months ended
June 30,
 
    
2023
    
2022
 
Net income applicable to common stock
   $ 12,885      $ 12,348  
Weighted average number of common shares outstanding
     6,263        6,385  
  
 
 
    
 
 
 
Basic earnings per share
   $ 2.06      $ 1.93  
  
 
 
    
 
 
 
Net income applicable to common stock
   $ 12,885      $ 12,348  
Weighted average number of common shares outstanding
     6,263        6,385  
Dilutive effect on common shares outstanding
     112        141  
  
 
 
    
 
 
 
Weighted average number of diluted common shares outstanding
     6,375        6,526  
  
 
 
    
 
 
 
Diluted earnings per share
   $ 2.02      $ 1.89  
  
 
 
    
 
 
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following schedule presents stock options granted but not exercised and the amount of share that were anti-dilutive because the weighted average exercise price equaled or exceeded the estimated fair value of our common stock for the three- and
six-month
periods ended June 30, 2023 and 2022:
 
    
Three months ended June 30,
 
    
2023
    
2022
 
            Weighted Ave             Weighted Ave  
     Options      Exercise Price      Options      Exercise Price  
Options to purchase
     276,704      $ 19.56        328,021      $ 17.65  
Anti-dilutive
     95,750      $ 32.45        95,750      $ 32.45  
 
    
Six months ended June 30,
 
    
2023
    
2022
 
            Weighted Ave             Weighted Ave  
     Options      Exercise Price      Options      Exercise Price  
Options to purchase
     280,732      $ 19.49        333,753      $ 16.31  
Anti-dilutive
     95,750      $ 32.45        95,750      $ 32.45